Български
  • English
International Cooperation and Development

Liberia

Liberia is recovering from a 10 year period of civil wars which ended in 2003 and the Ebola epidemic of 2016. Civil war destroyed the country’s infrastructure and significantly eroded a once large human capital base. The country is rich in resources but it's economy is dependent on commodity prices.

Our priorities

The EU is assisting the implementation of the government’s transitional economic development programme. After 2 devastating civil wars (1989-1996 and 1999-2003), this programme is consolidating national peace and putting the West African nation on a path of poverty reduction.

Our support is aligned to the Liberian ‘Agenda for Transformation’ which establishes 2 key objectives: to create wealth; and to increase inclusiveness for a more equal and just society. It identifies the following priorities:

  • peace, security and rule of law

  • infrastructure and economic transformation

  • human development

  • governance and public institutions

Our programmes

The 11th European Development Fund (EDF) National Indicative Programme (NIP) allocated €279 million for the 2014-2020 funding period. The focal sectors are:

Good governance – to contribute to Liberia's Agenda for Transformation objectives of wealth creation and increased inclusiveness for a more equal and just society

Energy – to increase access to renewable energy services and affordable power for communities and support economic transformation.

Education – to ensure equal access to a high-quality free and compulsory basic education and to a variety of skill development opportunities that lead to an improved livelihood.

Agriculture – to promote a robust, competitive, sustainable and modernised agriculture sector supportive of sustainable economic growth and development.

All the EU’s cooperation activities in Liberia take cross-cutting issues into account: capacity building, conflict-sensitive development and human rights, youth, the environment and the fight against HIV/AIDS.